RT Journal Article
SR Electronic
T1 Meta-analysis of 208,370 East Asians identifies 113 genomic loci and yields new non-immune cell relevant biological insights for systemic lupus erythematosus
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.22.20178939
DO 10.1101/2020.08.22.20178939
A1 Yin, Xianyong
A1 Kim, Kwangwoo
A1 Suetsugu, Hiroyuki
A1 Bang, So-Young
A1 Wen, Leilei
A1 Koido, Masaru
A1 Ha, Eunji
A1 Liu, Lu
A1 Sakamoto, Yuma
A1 Jo, Sungsin
A1 Leng, Rui-Xue
A1 Otomo, Nao
A1 Laurynenka, Viktoryia
A1 Kwon, Young-Chang
A1 Sheng, Yujun
A1 Sugano, Nobuhiko
A1 Hwang, Mi Yeong
A1 Li, Weiran
A1 Mukai, Masaya
A1 Yoon, Kyungheon
A1 Cai, Minglong
A1 Ishigaki, Kazuyoshi
A1 Chung, Won Tae
A1 Huang, He
A1 Takahashi, Daisuke
A1 Lee, Shin-Seok
A1 Wang, Mengwei
A1 Karino, Kohei
A1 Shim, Seung-Cheol
A1 Zheng, Xiaodong
A1 Miyamura, Tomoya
A1 Kang, Young Mo
A1 Ye, Dongqing
A1 Nakamura, Junichi
A1 Suh, Chang-Hee
A1 Tang, Yuanjia
A1 Motomura, Goro
A1 Park, Yong-Beom
A1 Ding, Huihua
A1 Kuroda, Takeshi
A1 Choe, Jung-Yoon
A1 Li, Chengxu
A1 Niiro, Hiroaki
A1 Park, Youngho
A1 Shen, Changbing
A1 Miyamoto, Takeshi
A1 Ahn, Ga-Young
A1 Fei, Wenmin
A1 Takeuchi, Tsutomu
A1 Shin, Jung-Min
A1 Li, Keke
A1 Kawaguchi, Yasushi
A1 Lee, Yeon-Kyung
A1 Wang, Yongfei
A1 Amano, Koichi
A1 Yang, Wanling
A1 Tada, Yoshifumi
A1 Yamaji, Ken
A1 Shimizu, Masato
A1 Atsumi, Takashi
A1 Suzuki, Akari
A1 Sumida, Takayuki
A1 Okada, Yukinori
A1 Matsuda, Koichi
A1 Matsuo, Keitaro
A1 Kochi, Yuta
A1 Japanese Research Committee on Idiopathic Osteonecrosis of the Femoral Head
A1 Kottyan, Leah C.
A1 Weirauch, Matthew T.
A1 Parameswaran, Sreeja
A1 Eswar, Shruti
A1 Salim, Hanan
A1 Chen, Xiaoting
A1 Yamamoto, Kazuhiko
A1 Harley, John B.
A1 Ohmura, Koichiro
A1 Kim, Tae-Hwan
A1 Yang, Sen
A1 Yamamoto, Takuaki
A1 Kim, Bong-Jo
A1 Shen, Nan
A1 Ikegawa, Shiro
A1 Lee, Hye-Soon
A1 Zhang, Xuejun
A1 Terao, Chikashi
A1 Cui, Yong
A1 Bae, Sang-Cheol
YR 2020
UL http://medrxiv.org/content/early/2020/08/25/2020.08.22.20178939.abstract
AB Systemic lupus erythematosus (SLE), an autoimmune disorder, has been associated with nearly 100 susceptibility loci1-8. Nevertheless, these loci only partially explain SLE heritability and provide limited biological insight. We report the largest study of SLE in East Asians (13,377 cases and 194,993 controls), identifying 233 association signals within 113 (46 novel) genetic loci. We detect six new lead missense variants and prioritize ten most likely putative causal variants, one of which we demonstrate exhibits allele-specific regulatory effect on ACAP1 in vitro. We suggest 677 effector genes with potential for drug repurposing, and provide evidence that two distinct association signals at a single locus act on different genes (NCF2 and SMG7). We demonstrate that SLE-risk variants overlap with cell-specific active regulatory elements, notably EBNA2-mediated super-enhancers in Epstein-Barr Virus-transformed B cells, and implicate the role for non-immune cells in SLE biology. These findings shed light on genetic and biological understandings of SLE.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledged the participants in this study. We appreciate the contribution of Japanese Research Committee on Idiopathic Osteonecrosis of the Femoral Head. We appreciate all contributors to BioBank Japan. Details are included in supplementary material. This research was supported by General Program (81872516, 81573033, 81872527, 81830019, 81421001), Young Program (81803117), Exchange Program (81881340424), and Science Fund for Creative Research Groups (31630021) of National Natural Science Foundation of China (NSFC), Distinguished Young Scholar of Provincial Natural Science Foundation of Anhui (1808085J08), National Program on Key Basic Research Project of China (973 Program) (2014CB541901), Science Foundation of Ministry of Education of China (213018A), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-12-0600), The Bio & Medical Technology Development Program of the National Research Foundation, funded by the Ministry of Science & ICT of the Republic of Korea (NRF-2017M3A9B4050355 to S.C.B.), Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (2015R1C1A1A02036527 and 2017R1E1A1A01076388 to K. Kim), National BioBank of Korea, the Centers for Disease Control and Prevention, Republic of Korea (KBN-2018-031 to S.S.L.), Center for Genome Science, Korea National Institute of Health, Republic of Korea (4845-301, 3000-3031 to M.Y.H., K. Yoon and B.J.K.), Japan Agency for Medical Research and Development (AMED) and the BioBank Japan project supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese Government and AMED under grant numbers (17km0305002 and 18km0605001), Grant of Japan Orthopaedics and Traumatology Research Foundation, lnc, (No.350 to Y.Sakamoto), RIKEN Junior Research Associate Program (to H.S.), US NIH grants (AI024717, AI130830, AI148276, HG172111 and AR070549 to J.B.H.), US Department of Veterans Affairs (BX001834 to J.B.H.), and Center for Pediatric Genomics Award and CCRF Endowed Scholar Award of Cincinnati Children’s Hospital (to M.T.W.). We appreciate the generous gift of pGL4.26 vector from Prof. Joon Kim at Graduate School of Medical Science Engineering, KAIST, Daejeon, South Korea.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:institutional review boards in participating institutionsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe ATAC-seq data for human blood B and T cells have been deposited with the China National Genomics Data Center (https://bigd.big.ac.cn/gsa-human/browse) under accession no. HRA000271. The expression quantitative trait loci summary-level data in blood immune cells are publicly available from our website (JENGER; http://jenger.riken.jp/en/). The meta-analysis summary-level results will be publicly available following 6 month embargo from the date of publication. All other data supporting the findings of this study are available within the paper and its supplementary information files and from the corresponding author upon reasonable request.